Search

everythinglearnresearchcommunity

for

Search:↓

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

Fumaric acid esters, especially dimethylfumarate, improve psoriasis treatment.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Combining standard treatment with exogenous cholinesterases can improve outcomes in severe organophosphate poisoning.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Tamsulosin is a cost-effective treatment for BPH symptoms.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Adenosine may promote hair growth by increasing FGF-7 levels in dermal papilla cells.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Certain substances can decrease or increase exploratory behavior in rodents.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.